Richard Champlin
Impact in
- Hematology top 0.01%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
Papers in
- Hematology 970
- Hematopoietic Stem Cell Transplantation 625
- Acute Myeloid Leukemia Research 302
- Chronic Myeloid Leukemia Treatments 183
- Multiple Myeloma Research and Treatments 161
- Genetics 261
- Chronic Lymphocytic Leukemia Research 149
- Co-authors
- Sergio Giralt (251 shared papers)Issa F. Khouri (219 shared papers)Börje S. Andersson (190 shared papers)Paolo N. Anderlini (153 shared papers)Robert Peter Gale (52 shared papers)Marcos J. G. De Lima (172 shared papers)Elizabeth J. Shpall (251 shared papers)Gabriela Rondón (230 shared papers)
- Journals
- Blood (370 papers)Transplantation and Cellular Therapy (264 papers)Bone Marrow Transplantation (94 papers)British Journal of Haematology (46 papers)American Journal of Hematology (40 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Richard Champlin
1.4k papers receiving 67.9k citations
Richard Champlin's Hit Papers
Peers
Comparison fields: 5 of 173
- Hematology 37.6k
- Genetics 11.6k
- Transplantation 2.4k
- Oncology 22.2k
- Immunology 18.0k
Countries citing papers authored by Richard Champlin
This map shows the geographic impact of Richard Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Champlin more than expected).
Fields of papers citing papers by Richard Champlin
This network shows the impact of papers produced by Richard Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Champlin. The network helps show where Richard Champlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Richard Champlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.4k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors Hit paper breakdown → | 2020 | 1743 |
| 2 | Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. Hit paper breakdown → | 1997 | 1077 |
| 3 | Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy Hit paper breakdown → | 1997 | 992 |
| 4 | Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia Hit paper breakdown → | 2004 | 898 |
| 5 | Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Hit paper breakdown → | 2002 | 805 |
| 6 | Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Hit paper breakdown → | 1998 | 791 |
| 7 | Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase Hit paper breakdown → | 1988 | 740 |
| 8 | 2004 | 710 | |
| 9 | Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity Hit paper breakdown → | 2017 | 689 |
| 10 | Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells Hit paper breakdown → | 2002 | 658 |
| 11 | Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study Hit paper breakdown → | 2007 | 654 |
| 12 | Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Hit paper breakdown → | 1988 | 633 |
| 13 | Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases Hit paper breakdown → | 2005 | 583 |
| 14 | 2000 | 578 | |
| 15 | Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia Hit paper breakdown → | 2015 | 550 |
| 16 | Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells Hit paper breakdown → | 2012 | 548 |
| 17 | 2001 | 493 | |
| 18 | 2010 | 476 | |
| 19 | 2001 | 476 | |
| 20 | 2012 | 463 |
About Richard Champlin
Richard Champlin is a scholar working on Hematology, Genetics, Oncology, Immunology and Public Health, Environmental and Occupational Health, having authored 1.4k papers that have together received 70.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (625 papers), Acute Myeloid Leukemia Research (302 papers), Acute Lymphoblastic Leukemia research (206 papers), Chronic Myeloid Leukemia Treatments (183 papers), Multiple Myeloma Research and Treatments (161 papers), Chronic Lymphocytic Leukemia Research (149 papers), Immune Cell Function and Interaction (144 papers) and Lymphoma Diagnosis and Treatment (125 papers). The work is most often cited by research in Hematology (37.6k citations), Genetics (11.6k citations), Transplantation (2.4k citations), Oncology (22.2k citations) and Immunology (18.0k citations). Richard Champlin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Sergio Giralt, Issa F. Khouri, Börje S. Andersson, Paolo N. Anderlini, Robert Peter Gale, Marcos J. G. De Lima, Elizabeth J. Shpall, Gabriela Rondón, Donna Przepiorka and Chitra M. Hosing. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, British Journal of Haematology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.